BSE Live
Dec 30, 11:58Prev. Close
2686.75
Open Price
2687.20
Bid Price (Qty.)
2728.65 (9)
Offer Price (Qty.)
2731.80 (3)
NSE Live
Dec 30, 11:58Prev. Close
2690.20
Open Price
2702.40
Bid Price (Qty.)
2730.30 (2)
Offer Price (Qty.)
2732.70 (13)
| Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.80 | 11.80 | 11.80 | 11.80 | 11.80 | |
| Total Share Capital | 11.80 | 11.80 | 11.80 | 11.80 | 11.80 | |
| Reserves and Surplus | 164.11 | 140.35 | 122.40 | 108.82 | 97.85 | |
| Total Reserves and Surplus | 164.11 | 140.35 | 122.40 | 108.82 | 97.85 | |
| Total Shareholders Funds | 175.91 | 152.15 | 134.20 | 120.62 | 109.65 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 142.36 | 147.35 | 89.66 | 49.75 | 35.31 | |
| Deferred Tax Liabilities [Net] | 12.32 | 13.12 | 7.55 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 154.68 | 160.47 | 97.21 | 49.75 | 35.31 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 60.93 | 92.87 | 75.40 | 58.73 | 47.45 | |
| Trade Payables | 66.59 | 44.55 | 38.71 | 36.49 | 26.89 | |
| Other Current Liabilities | 0.07 | 0.05 | 0.04 | 0.03 | 0.01 | |
| Short Term Provisions | 7.62 | 9.44 | 8.64 | 6.55 | 2.92 | |
| Total Current Liabilities | 135.21 | 146.92 | 122.80 | 101.81 | 77.27 | |
| Total Capital And Liabilities | 465.80 | 459.53 | 354.20 | 272.17 | 222.23 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 160.85 | 130.19 | 93.89 | 56.37 | 49.91 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 46.99 | 55.17 | 23.88 | 13.44 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 207.84 | 185.36 | 117.77 | 69.81 | 49.91 | |
| Non-Current Investments | 17.05 | 17.05 | 16.72 | 16.53 | 14.95 | |
| Deferred Tax Assets [Net] | 6.52 | 12.37 | 10.47 | 8.55 | 12.39 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 231.42 | 214.78 | 144.96 | 94.89 | 77.25 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 105.16 | 98.98 | 91.10 | 68.93 | 62.76 | |
| Trade Receivables | 85.50 | 94.47 | 83.13 | 75.72 | 69.35 | |
| Cash And Cash Equivalents | 5.23 | 7.31 | 4.91 | 6.06 | 2.34 | |
| Short Term Loans And Advances | 38.48 | 43.99 | 30.10 | 26.56 | 10.53 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 234.38 | 244.75 | 209.24 | 177.28 | 144.98 | |
| Total Assets | 465.80 | 459.53 | 354.20 | 272.17 | 222.23 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 10.43 | 24.85 | 16.23 | 9.59 | 18.47 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 34.78 | 37.41 | 14.48 | 13.73 | 11.43 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 1.80 | 1.75 | 5.07 | 1.77 | 0.52 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 26.33 | 17.85 | 10.83 | 6.16 | 7.28 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 0.01 | 0.01 | 0.00 | 0.00 | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 212.37 | 169.33 | 128.63 | 95.03 | 111.63 | |
| Other Earnings | 5.17 | 4.75 | 5.72 | 4.07 | 4.79 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 17.05 | 17.05 | 16.72 | 16.53 | 14.95 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
30.12.2025
26.12.2025
24.12.2025
Ajanta Pharma shares rise 5% on Biocon weight-loss drug marketing pact
24.12.2025
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct